Biommune Technologie (BIMUF) 0.1927 $BIMUF
BioMmune Technologies Inc. Announces Non-Brokered Private Placement
Marketwired - Sun May 03, 2:01PM CDT
BioMmune Technologies Inc. (the "Company"

(TSX VENTURE: IMU), announces a non-brokered private placement of up to 5,000,000 units (each a "Unit"

at a price of $0.20 per Unit for gross proceeds of up to $1,000,000. Each Unit will consist of one common share and one common share purchase warrant (each a "Warrant"

. Each Warrant entitles the holder to purchase one additional common share of the Company at a price of $0.30 per share for a period of eighteen months from the date of closing, subject to an exercise acceleration clause. Under the exercise acceleration clause, which the Company may exercise once the Units are free of resale restrictions and if the Company's shares are trading at or above a volume weighted average price of $0.50 for 10 consecutive trading days, the Warrants will expire upon 30 days from the date the Company provides notice in writing to the Warrant holders via a news release.
IMU.VN: 0.220 (-0.005)
BioMmune Technologies Inc. Announces the Appointment of Expert in Biologics as New Director
Marketwired - Tue Dec 16, 8:30AM CST
BioMmune Technologies Inc., (TSX VENTURE: IMU) a company focused on harnessing the body's own immune system to fight cancer and autoimmune diseases, today welcomes Professor Terry Pearson to the Board of Directors of BioMmune Technologies Inc.
IMU.VN: 0.220 (-0.005)